Month: June 2020

Print this page NOVATO, Calif. and TOKYO, June 18, 2020 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for rare and ultra-rare diseases, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company creating innovative medical solutions using the
0 Comments
June 18, 2020 Print this page Audience: Consumer, Health Professional, Pharmacy June 18, 2020 — GSK Consumer Healthcare is voluntarily recalling to the retail level two lots (listed below) of Children’s Robitussin® Honey Cough and Chest Congestion DM and one lot of Children’s Dimetapp® Cold and Cough, due to the inclusion of incorrect dosing cups.
0 Comments
The drug hydroxychloroquine, pushed by U.S. President Donald Trump and others in recent months as a possible treatment to people infected with the coronavirus disease (COVID-19), is displayed at the Rock Canyon Pharmacy in Provo, Utah, May 27, 2020. George Frey | Reuters The National Institutes of Health has halted its clinical trial of the anti-malaria drug hydroxychloroquine
0 Comments
Before patients with cancer begin treatment with intravenous fluorouracil and related drugs, they should be tested for lack of the enzyme dihydropyrimidine dehydrogenase (DPD), says an EU panel. This enzyme is involved in the metabolism of fluorouracil, as well as the related drugs capecitabine (Xeloda, Genentech) and tegafur, which are converted to fluorouracil in the
0 Comments
Transcatheter aortic valve replacement (TAVR) with the contemporary Sapien 3 device generally held up against surgery in intermediate-risk patients over 5 years, according to a propensity-matched analysis. Except for differences in stroke types, longer-term clinical outcomes were comparable between 783 matched pairs of patients undergoing TAVR with Sapien 3 and peers receiving surgical aortic valve
0 Comments
Leading to the death of over 460,000 people across the globe, coronavirus pandemic has reached a new “dangerous phase,” the World Health Organization confirmed. It came up as a warning from the authorities to make sure the public remains more cautious and prevented. According to WHO’s latest updates, the daily rise in infections as recorded
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. As nonurgent outpatient care reverts from telemedicine to in-person consultations, many practices are focusing on measures to prevent respiratory transmission of SARS-CoV-2, the virus that causes COVID-19. But experts emphasize that clinics shouldn’t ignore the role fomites can play in transmission.
0 Comments
Dr. Tom Scammell, Professor of Neurology at Harvard Medical School and a Sleep Medicine specialist provides an overview of narcolepsy. He discusses the symptoms of the disorder and why it occurs using animated illustrations of brain. He also provides insight into areas of research that may lead to better treatment for narcolepsy. Learn more at
0 Comments
Dear Chrissy, It’s June 20th, 2000, and right now you’re in the emergency department of the King’s Daughters Children’s Hospital in Norfolk, Virginia. You were supposed to be on a weeklong vacation with your siblings and parents, frolicking in the salty seawater and eating cotton candy on the boardwalk of Virginia Beach, but instead, on
0 Comments
Print this page EAST HANOVER, N.J., June 16, 2020 /PRNewswire/ — Novartis, a leader in rheumatology and immuno-dermatology, today announced that the US Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) for the treatment of active non-radiographic axial spondyloarthritis (nr-axSpA), confirming Cosentyx efficacy in addressing the axial spondyloarthritis (axSpA) disease spectrum9. “The results from
0 Comments
Neuroblastoma is one of the most common cancers in children and has limited treatment options. In a new study, researchers from Kanazawa University retrospectively analyzed children with refractory or relapsed high-risk neuroblastoma who were treated with 131I-metaiodobenzylguanidine (131I-MIBG) and discovered a favorable prognosis in these patients. Neuroblastoma forms in organs that embryologically originate from nerve
0 Comments
The newer iteration of the self-expanding Evolut valve was associated with small hemodynamic improvements when used for transcatheter aortic valve replacement (TAVR) in a degenerated surgical bioprosthesis notwithstanding a safety signal in real-world data. The Evolut PRO kept mean gradients lower compared with the Evolut R (13.2 vs 14.3 mm Hg at 1 year, P=0.023)
0 Comments
With the United States Medical Licensing Examination (USMLE) Step 2 Clinical Skills (CS) test suspended as a result of the COVID-19 pandemic, the Educational Commission for Foreign Medical Graduates (ECFMG) will now require an English proficiency test for international medical graduates (IMGs) to become certified for the match. On Wednesday, the ECFMG outlined its plan
0 Comments